The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...
Zacks Investment Research on MSN
TMDX dips after posting Q1 earnings & revenue miss, margins fall
TransMedics Group TMDX delivered earnings per share (EPS) of 30 cents in the first quarter of 2026, down 59.5% year over year ...
Needham analyst initiated coverage on TransMedics Group Inc (NASDAQ:TMDX), a commercial-stage medical technology company focused on organ transplant therapy for end-stage organ failure patients across ...
Innovations often (but not always) drive life-changing returns for the companies that engineer them and the people who get in on the ground floor. That's why investors should sometimes look toward ...
The traditional method for preserving organs during transport is placing organs on ice in a cooler. However, this method has several limitations. The organs are viable only for a few hours due to lack ...
TransMedics Group is a strong buy, leveraging its technological and logistical moat in organ transport, with OCS and NOP programs driving sector outperformance. TMDX trades at a 39x non-GAAP PE and ...
Read full article: Navigating HPV vaccine hesitancy: A doctor debunks myths, encourages cancer prevention Dr. Kyle Miletic, surgeon, talks about the procedure with heart transplant recipient Ken ...
ANDOVER, Mass., Feb. 9, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...
The Montreal Heart Institute and CHU Sainte-Justine are set to begin using a cutting-edge device that will expand access to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results